International Overdose Awareness Day: Raising Awareness, Reducing Stigma and Preventing Harm

International Overdose Awareness Day provides an important opportunity for healthcare professionals, organisations, communities and individuals to remember those whose lives have been lost or affected by overdose and to strengthen efforts to prevent future deaths. Observed globally on 31 August each year, the campaign also challenges the stigma surrounding drug use and encourages informed, compassionate conversations about overdose prevention.

For healthcare services across the UK, overdose remains a significant public health concern. It affects not only people who use illicit substances, but also their families, friends, healthcare professionals and wider communities. Effective prevention requires a combination of education, harm reduction, access to treatment, appropriate clinical intervention and a healthcare environment in which people feel able to seek help without fear of judgement.

The latest available Office for National Statistics figures underline the scale of the challenge. There were 5,565 deaths related to drug poisoning registered in England and Wales in 2024, representing the highest number since records began in 1993. Of these deaths, 2,621 involved opiates or opioids. The age-standardised mortality rate for drug-poisoning deaths has increased every year since 2012.

Further information is available from the Office for National Statistics:

Deaths related to drug poisoning in England and Wales – Office for National Statistics

These figures demonstrate why continued awareness, prevention and access to appropriate healthcare support remain so important.

What Is International Overdose Awareness Day?

International Overdose Awareness Day is the world’s largest annual campaign focused on ending overdose, remembering without stigma those who have died and acknowledging the grief experienced by families and friends.

Although one awareness day cannot solve the complex factors behind drug-related harm, it creates an important opportunity to bring the subject into public discussion. Conversations about overdose can encourage people to recognise risks, understand the signs of an emergency and learn where appropriate treatment and support can be accessed.

It is equally important that these conversations do not reinforce stigma. Substance dependence is a complex health and social issue. People may be affected by prescription medicines, illicit substances, combinations of drugs, alcohol, changing drug potency and many other factors.

A compassionate healthcare response therefore focuses on reducing harm and protecting life rather than making assumptions about an individual.

Why Overdose Awareness Remains Important in the UK

Drug-related deaths remain a serious concern across the UK, and emerging substances can create additional challenges for healthcare and harm-reduction services.

The ONS reported that 195 deaths registered in England and Wales in 2024 involved a nitazene, almost four times the number recorded in 2023. Nitazenes are highly potent synthetic opioids and illustrate how rapidly the risks within illicit drug markets can change.

Opioids continue to be particularly significant. In 2024, opiates and opioids were involved in 47.1% of registered drug-poisoning deaths in England and Wales.

These figures reinforce the importance of surveillance, public health intelligence, education, treatment services and appropriate harm-reduction measures.

International Overdose Awareness Day can therefore be used not simply to look back at lives lost, but to consider what healthcare organisations, communities and individuals can do differently to reduce preventable harm in the future.

Recognising an Opioid Overdose

Understanding the signs of a suspected opioid overdose can help people respond appropriately in an emergency.

Opioids can suppress the central nervous system and, critically, slow breathing. A person experiencing an opioid overdose may become extremely drowsy or unconscious and may not respond normally when spoken to or stimulated. Their breathing may become very slow, irregular or stop altogether.

A suspected overdose should always be treated as a medical emergency. Emergency medical assistance should be requested immediately.

Naloxone has an especially important role in opioid overdose response. UK Government guidance describes naloxone as the emergency antidote for overdoses caused by heroin and other opiates or opioids, including substances such as methadone, morphine, nitazenes and fentanyl.

Current UK Government guidance on take-home naloxone can be found here:

Supplying take home naloxone without a prescription – GOV.UK

The guidance also addresses important considerations including training, clinical governance, storage, record keeping and supply.

International Overdose Awareness Day and the Importance of Naloxone

One of the most important messages associated with International Overdose Awareness Day is that opioid overdose can be reversible when recognised and treated quickly.

Naloxone temporarily reverses the effects of opioids and can restore breathing in somebody experiencing an opioid overdose. However, administering naloxone does not replace the need for emergency medical care.

Increasing appropriate access to naloxone, alongside suitable training and awareness, can form an important part of harm-reduction strategies.

Healthcare professionals, drug and alcohol treatment services, community organisations and other eligible services all have potential roles in improving access and increasing public understanding.

The expansion of take-home naloxone provision in the UK reflects the principle that overdose prevention should extend beyond traditional clinical environments. An overdose may occur in a home, hostel, public space or community setting, making wider awareness particularly important.

The Role of Drug Screening in Healthcare

Drug screening can also form part of a wider clinical assessment or monitoring process in appropriate healthcare settings.

Rapid screening technologies can help healthcare professionals obtain preliminary information about whether particular drugs or drug metabolites may be present in a specimen. Depending on the clinical situation, this information may contribute to assessment, treatment planning, monitoring or further investigation.

Niche Healthcare supplies a range of clinical testing products, including the Opiate OPI Rapid Urine Test Device:

Opiate OPI Rapid Urine Test Device – Niche Healthcare

The device provides qualitative, presumptive detection of opiates in human urine specimens. As with rapid screening tests generally, results need to be interpreted in accordance with the manufacturer’s instructions and within the wider clinical context.

For settings where screening for several drug classes may be required, Niche Healthcare also supplies the Multi-drug Rapid Urine Test Panel:

Multi-drug Rapid Urine Test Panel – Niche Healthcare

Multi-drug panels can provide preliminary screening for several drugs or drug classes from one urine sample, depending on the configuration of the test.

Importantly, rapid screening should not be confused with diagnosing an overdose. A suspected overdose is an emergency requiring immediate clinical action, and screening should never delay emergency treatment.

Screening Results Require Appropriate Interpretation

While rapid drug tests can provide useful preliminary information, healthcare professionals should understand their limitations.

A screening result indicates whether a substance or metabolite has been detected relative to the test’s specified threshold. It does not necessarily establish how much of a substance was taken, when it was taken, whether the individual is intoxicated or whether a particular substance caused their symptoms.

There may also be circumstances where confirmatory laboratory testing is appropriate, particularly where a definitive identification is clinically or legally important.

Good practice therefore requires healthcare professionals to consider test results alongside clinical presentation, medical history, prescribed medication and other relevant information.

This distinction is particularly important when discussing overdose. Clinical assessment and emergency treatment should always take priority when an individual is seriously unwell.

Reducing Stigma Around Drug Use and Overdose

One of the central purposes of International Overdose Awareness Day is to challenge stigma.

Stigmatising language and attitudes can have practical consequences. If people believe they will be judged or treated differently because of substance use, they may be less willing to disclose what they have taken, engage with treatment services or seek help during an emergency.

Healthcare professionals are in a particularly important position to create a supportive environment.

Using neutral, person-centred language can help. Rather than defining someone by their substance use, healthcare conversations can focus on the individual, their immediate health needs and the support available to them.

This approach is not simply about language. It contributes to patient safety because obtaining accurate information can help healthcare professionals make better-informed clinical decisions.

Safety, Hygiene and Governance in Drug Testing

Where drug screening forms part of a healthcare service, appropriate infection prevention and clinical governance procedures remain essential.

Urine specimens are biological materials and should be handled using suitable precautions. Staff should follow local infection prevention procedures, use appropriate personal protective equipment where required and ensure specimens and used testing materials are disposed of according to relevant clinical waste procedures.

Testing devices should also be stored according to the manufacturer’s specified conditions and should not be used beyond their stated expiry date. Staff carrying out testing should understand the instructions for use, required reading times, control indicators and interpretation criteria.

These basic procedures help support consistent and reliable testing while protecting both patients and healthcare professionals.

Niche Healthcare supports hospitals, clinics, laboratories and healthcare procurement teams with a broad range of laboratory, diagnostic and clinical supplies:

Healthcare Supplies UK | NHS Medical Supplier | Niche Healthcare

Overdose Prevention Requires a Wider Healthcare Approach

Preventing overdose cannot depend upon one product, intervention or organisation.

Effective harm reduction requires collaboration between healthcare services, drug and alcohol treatment providers, public health teams, emergency services, pharmacies, voluntary organisations, families and communities.

Education can help people understand risks. Treatment services can help people manage dependence. Naloxone can provide a critical emergency intervention in opioid overdose. Clinical testing can provide information in appropriate circumstances. Public health surveillance can identify changing patterns of harm.

Together, these interventions contribute to a more informed and responsive healthcare system.

The increasing presence of highly potent synthetic opioids also means healthcare and public health organisations need to remain alert to changing patterns of drug use. Current guidance, staff education and effective communication between services are increasingly important as the substances circulating within communities evolve.

Remembering Those Affected by Overdose

Behind every drug-related death is a person.

Statistics are essential for understanding the scale of the problem, but International Overdose Awareness Day is also about recognising the human impact of overdose.

Families may experience grief, uncertainty and stigma following a drug-related death. Friends, colleagues and healthcare professionals may also be profoundly affected.

Remembering people with dignity helps reinforce an important principle: drug-related deaths should never simply become numbers within annual statistics.

Awareness should ultimately lead to action. That may mean improving access to naloxone, strengthening referral pathways, reviewing local harm-reduction policies, educating staff or simply creating an environment where somebody feels able to ask for help.

Frequently Asked Questions

When is International Overdose Awareness Day?

International Overdose Awareness Day takes place annually on 31 August. It is a global campaign focused on raising awareness of overdose, reducing stigma and remembering people whose lives have been lost or affected by overdose.

What should someone do if they suspect an overdose?

A suspected overdose should be treated as a medical emergency. Emergency medical assistance should be requested immediately. Where an opioid overdose is suspected and naloxone is available, appropriately trained individuals may administer it in accordance with applicable guidance while awaiting emergency assistance.

What is naloxone?

Naloxone is an emergency medicine that temporarily reverses the effects of opioids. UK Government guidance identifies it as an antidote for overdose involving opioids including heroin, methadone, morphine, fentanyl and nitazenes. Further information is available at Supplying take home naloxone without a prescription – GOV.UK

Can a rapid urine drug test diagnose an overdose?

No. Rapid urine drug tests are screening tools and should not be used as a substitute for clinical assessment or emergency treatment. They may provide preliminary information about the presence of particular drugs or metabolites, but they cannot independently determine whether someone is experiencing an overdose.

Why is reducing stigma important?

Stigma can discourage people from discussing substance use or accessing healthcare and treatment services. Compassionate, person-centred communication can support engagement with healthcare services and help professionals obtain information that may be important for safe and appropriate treatment.

Conclusion: Supporting International Overdose Awareness Day

International Overdose Awareness Day reminds healthcare professionals, organisations and communities that behind every statistic is an individual, a family and a wider network of people affected by overdose.

The latest figures for England and Wales demonstrate that drug-related harm remains a substantial public health challenge. With 5,565 drug-poisoning deaths registered in 2024 and opioids involved in almost half of those deaths, continued investment in prevention, education, naloxone availability, treatment and compassionate healthcare remains essential.

Healthcare organisations can contribute by maintaining awareness, supporting evidence-based harm-reduction approaches, ensuring staff have access to appropriate training and using diagnostic and screening technologies responsibly where clinically appropriate.

Niche Healthcare is committed to supporting healthcare organisations with reliable clinical, diagnostic and laboratory supplies while recognising that products are only one component of a much broader approach to patient safety and effective healthcare.

International Overdose Awareness Day should ultimately be about more than awareness. It is an opportunity to remember those who have died, support those who remain at risk, challenge stigma and reinforce a shared commitment to preventing avoidable loss of life.

 

 

See our full selection:

Healthcare Supplies in Aberdeen | Niche Healthcare

Healthcare Supplies in Basildon | Niche Healthcare

Healthcare Supplies in Basingstoke | Niche Healthcare

Healthcare Supplies in London | Niche Healthcare

 

For procurement details, bulk purchasing, and further product information, contact our team today on 01274 965089 or check out our website at www.nicheofficesolutions.co.uk / www.nicheofficesolutions.co.uk/niche-nhs

Further clinical information can be found on our blog page: www.nicheofficesolutions.co.uk/category/niche-healthcare-news

For products not found on our online website, please view our Healthcare catalogues: www.nicheofficesolutions.co.uk/healthcare-catalogues

View our Healthcare YouTube videos Playlist

If you have any additional questions, drop us an email at info@nicheofficesolutions.co.uk